SCHEMBL4156820

SCHEMBL4156820

CC(=O)C(CCC(C)C)C(=O)NCCc1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.47
CNR1 P21554 1/20 0.46
OPRM1 P35372 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
ANPEP P15144 1/20 0.44
TP53 P04637 1/20 0.42
VNN1 O95497 1/20 0.42
OPRL1 P41146 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4140439 0.86 TAAR1 (0.50) TAAR1CNR1OPRM1OPRD1OPRK1
SCHEMBL22857525 0.82 TAAR1 (0.57) TAAR1CNR1OPRM1KMT2AOPRD1
SCHEMBL1010528 0.77 TAAR1 (0.62) TAAR1CNR1OPRM1ALDH1A1HPGD
SCHEMBL12930792 0.77 TAAR1 (0.53) TAAR1MEN1KMT2A
SCHEMBL4142774 0.75 CNR1 (0.44) TAAR1CNR1OPRM1MEN1ALDH1A1
SCHEMBL4142778 0.75 CNR1 (0.44) TAAR1CNR1OPRM1MEN1ALDH1A1
SCHEMBL4142769 0.75 CNR1 (0.44) TAAR1CNR1OPRM1MEN1ALDH1A1
SCHEMBL5117230 0.72 CNR1 (0.59) TAAR1CNR1OPRM1ALDH1A1OPRD1
SCHEMBL4138386 0.72 MMP8 (0.65) MEN1ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL4145237 0.72 POLB (0.57) MEN1ALDH1A1HPGDKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137557-A1 Calcilytic Compounds CALCR, SOST, CALCB TAAR1 4308/4885CNR1 1655/4885OPRM1 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.